TCL Archive In Senate testimony, NCI director uses survival rate as measure of progress for goal to “eliminate suffering and death due to cancer.” July 29, 2005
TCL Archive NCCTG Plans To Conduct Phase II Study Of Brostallicin Plus Cisplatin For mTNBC April 30, 2010
TCL Archive In Brief: Schmidt Asks NCI Grantees, Contractors To tell Him How They Waste Cancer Money December 13, 1974